ScholarIQanswers from OpenAlex

Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis

PaperCitations, authors & open-access status

Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis have?

ScholarIQcitation count

Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis has 201 citations in the OpenAlex counts ScholarIQ stores.

When was Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis published?

ScholarIQyear

Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis has 2017 year in the ScholarIQ index.

What is the open-access status of Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis?

ScholarIQoa status

Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis has hybrid oa status in the ScholarIQ index.

What is the DOI of Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis?

ScholarIQdoi

The DOI for Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis is on the source record.

What is the PMID of Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis?

ScholarIQpmid

The PMID for Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis is on the source record.

What is the OpenAlex record for Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis?

ScholarIQopenalex

The OpenAlex for Lurasidone compared to other atypical antipsychotic monotherapies for bipolar depression: A systematic review and network meta-analysis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial